Tricyclic indole mcl-1 inhibitors and uses thereof
US-2016106731-A1 · Apr 21, 2016 · US
US11149024B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11149024-B2 |
| Application number | US-201816497919-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 29, 2018 |
| Priority date | Mar 31, 2017 |
| Publication date | Oct 19, 2021 |
| Grant date | Oct 19, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are intermediates and methods of synthesizing Compound 1.
Opening claim text (preview).
The invention claimed is: 1. A compound selected from: or a salt thereof. 2. A salt of claim 1 , which is:
directly linked by a ring-member-to-ring-member bond · CPC title
with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms · CPC title
with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings · CPC title
to carbon atoms of a saturated carbon skeleton · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.